# Avopef

NDC: 83831-144
Generic name: etoposide
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260213

FDA application: NDA220200

## Active ingredients

- ETOPOSIDE: 100 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-144"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-144
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acc1e443-ef7b-486f-a638-710a20e81059